Concurrent 2B: Prison Health for People Who Use Drugs
Tracks
Track 2
| Wednesday, October 15, 2025 |
| 4:00 PM - 5:30 PM |
Details
This session explores strategies for integrating drug treatment programs into prisons and their impact on post-release outcomes, the impact of peer-led hepatitis C screening in carceral settings, and approaches to expanding HCV services. Case studies, including Australia, Kenya, and the UK will highlight real-world successes and challenges in improving health outcomes for incarcerated populations.
Speaker
Conjoint Prof Adrian Dunlop
Director, Senior Staff Specialist
Drug & Alcohol Clinical Services, HNE Health
Integrating Treatment for Opioid Dependence into Prisons: Impact and Post-Release Outcomes
4:00 PM - 4:20 PMBiography
Miss Julia Sheehan
Women's Prisons Manager
The Hepatitis C Trust
Trust, Test, Treat: The Impact of Peer-Led Hepatitis C Screening in Carceral Facilities
4:40 PM - 5:00 PMBiography
Julia has 10 years’ experience of working with people at risk of viral hepatitis – people in prison, substance users, homeless and migrants.
Passionate about the rights of and equality for women affected by the criminal justice system, Julia joined the Hepatitis C Trust in 2018 as the Women’s Prison Peer support lead, in 2019 Julia took over the lead role and today is the Women’s National Criminal Justice Manager.
Diagnosed with hepatitis C in 2007, Julia cleared the virus in 2017 after taking DDA’s.
